Results 41 to 50 of about 52,796 (199)

Pituitary tumors in the elderly [PDF]

European Journal of Endocrinology, 1999
The proportion of elderly subjects is growing in Western countries and, as a consequence, several diseases are now recognized with increasing frequency in the older segment of the population. Pituitary tumors are no exception to the rule. However, the presentation, diagnosis and management of pituitary tumors in the elderly, defined as patients older ...
openaire   +3 more sources

Clinical study of endoscopic treatment of a sellar pituitary adenomas with sellar diaphragm defect

BMC Neurology, 2020
Background Invasive growth of pituitary macroadenomas to the suprasellar region occurs commonly. Pituitary adenomas show varying growth patterns when the sellar diaphragm is absent, and they are often confused with other common tumors in the sellar ...
Zhuoru Jin, Xinyu Wu, Yibao Wang
doaj   +1 more source

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review

Journal of Education, Health and Sport, 2019
Introduction: Pituitary adenomas are generally benign central nervous system neoplasms with still increasing prevalence, especially in younger people.
Joanna Szydełko, Michał Litwińczuk, Magdalena Szydełko   +2 more
doaj   +3 more sources

Suspected silent pituitary somatotroph neuroendocrine tumor associated with acromegaly-like bone disorders: a case report

BMC Endocrine Disorders
Background Growth hormone (GH) positive pituitary neuroendocrine tumors do not always cause acromegaly. Approximately one-third of GH-positive pituitary tumors are classified as non-functioning pituitary tumors in clinical practice.
Tongxin Xiao, Xinxin Mao, Ou Wang, Yong Yao, Kan Deng, Huijuan Zhu, Lian Duan   +6 more
doaj   +1 more source

Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions

Frontiers in Endocrinology, 2018
Temozolomide, an alkylating agent, initially used in the treatment of gliomas was expanded to include pituitary tumors in 2006. After 12 years of use, temozolomide has shown a notable advancement in pituitary tumor treatment with a remarkable improvement
Luis V. Syro, Fabio Rotondo, Mauricio Camargo, Leon D. Ortiz, Carlos A. Serna, Kalman Kovacs   +5 more
doaj   +1 more source

Recent Progress in the Medical Therapy of Pituitary Tumors [PDF]

Endocrinology and Metabolism, 2017
Management of pituitary tumors is multidisciplinary, with medical therapy playing an increasingly important role. With the exception of prolactin-secreting tumors, surgery is still considered the first-line treatment for the majority of pituitary ...
Fabienne Langlois, Shirley McCartney, Maria Fleseriu   +2 more
doaj   +1 more source

Sellar plasmacytoma with massive bleeding during surgery

Cancer Treatment and Research Communications, 2022
Plasmacytoma in the sellar region is an extremely rare occurrence. Sellar plasmacytoma is often difficult to differentiate from pituitary tumors both clinically and radiologically.
Dong Hoon Lee, Jo Heon Kim, Woo Youl Jang, Shin Jung, Sang Chul Lim   +4 more
doaj  

Pituitary Metastasis of Clear Cell Renal Carcinoma Mimicking Pituitary Macroadenoma – Case Report

Brazilian Neurosurgery
Introduction Pituitary tumors account for 25% of all primary brain tumors and for 15% of overall intracranial expansive masses. Pituitary metastases, in contrast, are a rare condition, estimated as 1.8% of all resected sellar lesions.
Lucas Caixeta Nogueira, Luciano Ricardo França da Silva, Luiz Eduardo Mendonça Tenório, Cleiton Onofre de Menezes, João Victor Franco de Oliveira Calado, Luiz Felipe Gomes Rosa, Guilherme Figner Moussalem, Nicolai Máximo Leventi   +7 more
doaj   +1 more source

Pituitary metastasis of small cell lung cancer: Two case reports

Journal of Clinical and Translational Endocrinology Case Reports, 2021
Pituitary metastasis is a rare manifestation of systemic malignancy accounting for approximately 1% of all pituitary tumors. Breast and lung tumors are the most common primary sources of metastases, yet other sites such as the gastrointestinal tract ...
Beatriz Martinez Quintero, Keli Kobla Doe, Brandon Bunker, Woon Chow, Sahzene Yavuz   +4 more
doaj  

Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas.

PLoS ONE, 2014
Pituitary adenomas are neoplasms of the anterior pituitary lobe and account for 15-20% of all intracranial tumors. Although most pituitary tumors are benign they can cause severe symptoms related to tumor size as well as hypopituitarism and/or ...
Hande Demir, Iikki Donner, Leena Kivipelto, Outi Kuismin, Camilla Schalin-Jäntti, Ernesto De Menis, Auli Karhu   +6 more
doaj   +1 more source